Dublin, Oct. 25, 2016 -- Research and Markets has announced the addition of the "Infusion Pumps & Accessories Global Market - Forecast to 2022" report to their offering.
Among the infusion pumps & accessories, applications market anaesthesia/critical care/pain management segment holds the largest share and endocrinology is expected to be the fastest-growing segment from 2015 to 2022. In products, market disposables hold the largest share of the market with a strong CAGR of 6.2%. In end- users, hospitals segment is the largest market and homecare is the fastest growing segment from 2015 to 2022.Geographically, North America is the largest market followed by Europe and Asia-Pacific.
The APAC region is the fastest growing region from 2015 to 2022 presenting an array of opportunities for growth and is likely to get the attention of new investors in the infusion pumps & accessories market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The infusion pumps & accessories market are expected to grow at a mid-range single digit CAGR during 2015 to 2022. The increase in ageing population and subsequent rise in the incidence of chronic diseases, technological innovations offering a wider scope of applications for infusion pumps and increase in use of infusion products in homecare setting are the factors driving the market growth. The increasing trend for wireless infusion pumps, the emergence of smart pumps and market expansion opportunities in emerging nations are expected to offer potential opportunities.
However, various factors like patient safety risks and medication errors associated with infusion pumps, lack of cyber security in wireless infusion pumps limit the growth of infusion pumps & accessories global market. The threats for the infusion pumps & accessories market include increasing number of infusion pump product recalls due to FDA mandates and stringent regulatory bodies guiding the infusion pump manufacturers.
The infusion pumps & accessories global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.
Some of the key players of the infusion pumps & accessories market are Johnson & Johnson (U.S.), Terumo Corporation (Japan), Medtronic plc (Ireland), Pfizer, Inc. (U.S.), Becton Dickinson & Company (U.S.), Smiths Medical (U.K.), Fresenius Kabi (Germany), Roche Diagnostics (Switzerland), Moog Inc (U.S.), Baxter International, Inc. (U.S.) and B. Braun Melsungen AG (Germany).
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
4 Infusion Pumps & Accessories Global Market, By Application
5 Infusion Pump & Accessories Global Market, By Products
6 Infusion Pumps & Accessories Global Market, By Mode Of Administration
7 Infusion Pumps & Accessories Global Market, By End-Users
8 Infusion Pumps & Accessories Global Market, By Geography
9 Company Developments
10 Company Profiles
Companies Mentioned
- Ace Medical
- Advanced Instrumentations
- Angel Canada Enterprises
- Arcomed Ag Medical Systems
- Arrow International
- Asante
- Atena
- B Braun Melsungen Ag
- Bard
- Baxter International Inc
- Becton Dickinson & Company
- Biomedical Solutions
- Caesarea Medical Electronics
- Canafusion
- Cane Medical Technology
- Carewell Healthcare
- Cellnovo Ltd
- CME America Llc
- Codan Argus Ag
- Codman & Shurtleff Inc
- Eternity Electronic Technology Co Ltd
- Flowonix Medical Inc
- Fresenius Kabi
- Gamidatech
- Go Medical Industries Pty Ltd
- Guangzhou Medsinglong Medical Equipment Co Ltd
- Halyard Health
- Hemodiaz Life Sciences Pvt Ltd
- Holmarc
- Icu Medicals Inc
- I-Flow Corporation
- Insulet Corporation
- Intrapump
- Iradimed Corporation
- Johnson & Johnson
- KD Scientific Inc
- Leventon
- Lutech Industries Inc
- Medasys Inc
- Medline Industries Inc
- Medtronic Plc
- Micromed
- Microport
- Mindray Medical International Limited
- Mircel Medical Devices
- Moog Inc
- Nipro Medical Corporation
- Novo Nordisk
- Optioncare
- Pfizer Inc
- Pfm Medical
- Plenum Tech Pvt Ltd
- Progetti Medical Equipment Solutions
- Q-Core
- Rigel Medical
- Rms Medical Products
- Roche Diagnostics
- Shanghai Berry Electronic Tech Co Ltd
- Skanray Technologies Pvt Ltd
- Smiths Medical
- Sooil Development Co Ltd
- Stryker
- Summit Medical Products Inc
- Tandem Diabetes Care Inc
- Terumo Corporation
- Vogt Medical
- Xeris Pharmaceuticals Inc
- Ypsomed
- Zerone Co Ltd
- Zhejiang Fert Medical Device Co Ltd
- Zyno Medical Llc
For more information about this report visit http://www.researchandmarkets.com/research/dh3gwc/infusion_pumps
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infusions and Injectables , Needles and Syringes


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Italy Fines Apple €98.6 Million Over App Store Dominance
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



